Amedisys Stock Price on November 14, 2024
| AMED Stock | USD 85.15 0.08 0.09% |
Below is the normalized historical share price chart for Amedisys extending back to August 17, 1994. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Amedisys stands at 85.15, as last reported on the 25th of December, with the highest price reaching 85.20 and the lowest price hitting 84.43 during the day.
If you're considering investing in Amedisys Stock, it is important to understand the factors that can impact its price. Amedisys secures Sharpe Ratio (or Efficiency) of -0.19, which signifies that the company had a -0.19% return per unit of standard deviation over the last 3 months. Amedisys exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Amedisys' mean deviation of 0.5902, and Risk Adjusted Performance of (0.14) to double-check the risk estimate we provide.
At present, Amedisys' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. . At present, Amedisys' Price To Operating Cash Flows Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Free Cash Flows Ratio is expected to grow to 26.05, whereas Price Earnings Ratio is projected to grow to (301.02). Amedisys Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 17th of August 1994 | 200 Day MA 94.1143 | 50 Day MA 91.3876 | Beta 0.782 |
Amedisys |
Sharpe Ratio = -0.1918
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AMED |
Estimated Market Risk
| 1.06 actual daily | 9 91% of assets are more volatile |
Expected Return
| -0.2 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.19 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Amedisys is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Amedisys by adding Amedisys to a well-diversified portfolio.
Price Book 2.4277 | Enterprise Value Ebitda 13.3024 | Price Sales 1.2016 | Shares Float 32.1 M | Wall Street Target Price 96.3333 |
Related Headline
Addus HomeCare Headline on 14th of November 2024
Equities Research Analysts Updated EPS Estimates for Novembe... by thelincolnianonline.com
Equities Research Analysts updated eps estimates for Thursday, November 14th Acrivon Therapeutics had its buy rating reissued by analysts at HC Wainwright. The firm currently has a 22.00 target price on the stock. Acurx Pharmaceuticals had its buy rating reiterated by analysts at HC Wainwright. They currently have a 12.00 target price on
Amedisys Valuation on November 14, 2024
It is possible to determine the worth of Amedisys on a given historical date. On November 14, 2024 Amedisys was worth 90.77 at the beginning of the trading date compared to the closed value of 90.29. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Amedisys stock. Still, in general, we apply an absolute valuation method to find Amedisys' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Amedisys where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Amedisys' related companies.
| Open | High | Low | Close | Volume | |
| 90.99 | 91.90 | 89.83 | 90.49 | 973,342 | |
11/14/2024 | 90.77 | 91.07 | 90.17 | 90.29 | 363,631 |
| 90.18 | 90.47 | 89.80 | 90.05 | 501,387 |
| Backtest Amedisys | | | Amedisys History | | | Amedisys Valuation | Previous | Next |
Amedisys Trading Date Momentum on November 14, 2024
| On November 15 2024 Amedisys was traded for 90.05 at the closing time. The top price for the day was 90.47 and the lowest listed price was 89.80 . The trading volume for the day was 501.4 K. The trading history from November 15, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.27% . The overall trading delta against the current closing price is 0.51% . |
Amedisys Fundamentals Correlations and Trends
By evaluating Amedisys' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Amedisys' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Amedisys financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Amedisys Stock history
Amedisys investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Amedisys is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Amedisys will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Amedisys stock prices may prove useful in developing a viable investing in Amedisys
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 32.6 M | 23.4 M | |
| Net Income Applicable To Common Shares | 136.4 M | 143.2 M |
Amedisys Stock Technical Analysis
Amedisys technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Amedisys Period Price Range
Low | December 25, 2024
| High |
0.00 | 0.00 |
Amedisys cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Amedisys December 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Amedisys stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Amedisys shares will generate the highest return on investment. By undertsting and applying Amedisys stock market strength indicators, traders can identify Amedisys entry and exit signals to maximize returns
Amedisys Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Amedisys' price direction in advance. Along with the technical and fundamental analysis of Amedisys Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Amedisys to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.14) | |||
| Jensen Alpha | (0.21) | |||
| Total Risk Alpha | (0.24) | |||
| Treynor Ratio | (0.75) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Amedisys Stock analysis
When running Amedisys' price analysis, check to measure Amedisys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amedisys is operating at the current time. Most of Amedisys' value examination focuses on studying past and present price action to predict the probability of Amedisys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amedisys' price. Additionally, you may evaluate how the addition of Amedisys to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |